| American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock | Critical Care Medicine | 2017 | 297 |
| Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment | Journal of Allergy and Clinical Immunology | 2017 | 153 |
| Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go | American Journal of Respiratory and Critical Care Medicine | 2017 | 119 |
| Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease | BMJ Open Respiratory Research | 2017 | 107 |
| Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes | American Journal of Respiratory and Critical Care Medicine | 2017 | 68 |
| Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis | DMM Disease Models and Mechanisms | 2017 | 65 |
| The role of periostin in lung fibrosis and airway remodeling | Cellular and Molecular Life Sciences | 2017 | 64 |
| Dysbiosis in the intensive care unit: Microbiome science coming to the bedside | Journal of Critical Care | 2017 | 59 |
| Macrophage-derived apoptotic bodies promote the proliferation of the recipient cells via shuttling microRNA-221/222 | Journal of Leukocyte Biology | 2017 | 58 |
| Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 58 |
| Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis | Mucosal Immunology | 2017 | 55 |
| Changes in Primary Noncardiac Diagnoses Over Time Among Elderly Cardiac Intensive Care Unit Patients in the United States | Circulation: Cardiovascular Quality and Outcomes | 2017 | 54 |
| The diagnosis of idiopathic pulmonary fibrosis: current and future approaches | Lancet Respiratory Medicine,the | 2017 | 52 |
| Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study | European Respiratory Journal | 2017 | 50 |
| The American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: Executive Summary | Pediatric Critical Care Medicine | 2017 | 44 |
| Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS | American Journal of Respiratory and Critical Care Medicine | 2017 | 44 |
| Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions | Translational Research | 2017 | 39 |
| IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia | Mucosal Immunology | 2017 | 38 |
| The significance of Candida in the human respiratory tract: our evolving understanding | Pathogens and Disease | 2017 | 37 |
| Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome | Pediatric Critical Care Medicine | 2017 | 35 |
| IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis | FASEB Journal | 2017 | 34 |
| Metabolomics as a Driver in Advancing Precision Medicine in Sepsis | Pharmacotherapy | 2017 | 33 |
| Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition | Annals of the American Thoracic Society | 2017 | 31 |
| Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2 | PLoS Pathogens | 2017 | 30 |
| Microbiome in interstitial lung disease: from pathogenesis to treatment target | Current Opinion in Pulmonary Medicine | 2017 | 30 |
